eCite Digital Repository
Evaluation of levamisole as a treatment for amoebic gill disease of Atlantic salmon, Salmo salar L
Citation
Findlay, VL and Zilberg, D and Munday, BL, Evaluation of levamisole as a treatment for amoebic gill disease of Atlantic salmon, Salmo salar L, Journal of Fish Diseases, 23, (3) pp. 193-198. ISSN 0140-7775 (2000) [Refereed Article]
DOI: doi:10.1046/j.1365-2761.2000.00238.x
Abstract
Levamisole, a known T-cell stimulator and immunomodulator in mammals, has been demonstrated to enhance resistance to amoebic gill disease in Atlantic salmon, Salmo salar L. When used in fresh water baths, dose rates of 1.25, 2.5 and 5 ppm levamisole stimulated resistance to reinfection with Paramoeba sp. that was evident from 2-3 weeks post-treatment. It is proposed that this response is related to enhancement of the non-specific immune system.
Item Details
| Item Type: | Refereed Article |
|---|---|
| Research Division: | Agricultural, Veterinary and Food Sciences |
| Research Group: | Fisheries sciences |
| Research Field: | Fish pests and diseases |
| Objective Division: | Animal Production and Animal Primary Products |
| Objective Group: | Fisheries - aquaculture |
| Objective Field: | Fisheries - aquaculture not elsewhere classified |
| UTAS Author: | Zilberg, D (Dr Dina Zilberg) |
| UTAS Author: | Munday, BL (Dr Barry Munday) |
| ID Code: | 19014 |
| Year Published: | 2000 |
| Web of Science® Times Cited: | 33 |
| Deposited By: | TAFI - Aquaculture |
| Deposited On: | 2000-08-01 |
| Last Modified: | 2011-11-07 |
| Downloads: | 0 |
Repository Staff Only: item control page